GSP Crop Science Limited, a leading agrochemical manufacturer of technicals and formulations, presents GSP Crop Science IPO on BSE and NSE mainboard opening March 16, 2026, closing March 18, 2026, with listing on March 24, 2026. The IPO size aggregates ₹400 crore through 1.25 crore equity shares at ₹304 – ₹320 price band, comprising ₹240 crore fresh issue for debt repayment and capacity expansion plus ₹160 crore offer for sale by promoters. GSP Crop Science IPO capitalizes on rising precision agriculture adoption and global agrochem demand resurgence.
₹00
₹320
₹
Expert Opinions
Market sentiment for GSP Crop Science IPO shows steady interest from agri-input investors, supported by established technical manufacturing capabilities despite commodity price cycle pressures. Company strengths include 507 product registrations, 89 granted patents contributing 20% sales, integrated technical-to-formulation chain, 40% export revenue diversification, and ₹1,152 crore FY24 topline stability.
Risks and challenges feature regulatory re-registration deadlines, raw material volatility impacting 60% costs, 35% debt/equity leverage requiring ₹200 crore repayment, customer concentration risks, and Chinese import competition eroding domestic pricing power. Valuation analysis of GSP Crop Science IPO and year 2025 reveals Return on Equity (ROE) of 18.38%, ROCE of 19.80%, and Net Asset Value (NAV) of ₹115.34, positioned at 25-30x P/E competitive versus UPL PI peers averaging 35x. Long-term investment perspective benefits from 10% crop protection CAGR through precision agriculture adoption and export market penetration.
Investor Considerations
GSP Crop Science IPO demonstrates stable company performance and fundamentals in FY25, maintaining ₹1,152 crore revenue through diversified agrochemical technicals and formulations across domestic export markets. Agrochemical sector outlook sustains 10% CAGR driven by precision farming adoption and export demand growth. IPO Valuation of Financial Year 2025 for GSP Crop Science IPO and year shows EBITDA Margin of 12.74%, PAT Margin of 6.26%, and Debt/Equity of 0.58, reflecting operational efficiency post ₹200 crore debt reduction.
Growth prospects leverage 507 product registrations, new technical manufacturing capacities, and 40% export revenue targeting expansion. Risk factors include regulatory re-registration deadlines, raw material price volatility affecting 60% costs, Chinese import competition, customer concentration pressures, and monsoon dependency. Short-term investment goals monitor listing stability amid commodity cycles, while long-term horizons capture sustained crop protection demand and innovation pipeline execution.
| Date | GMP | Trend |
|---|---|---|
| 22 Mar 2026 11.43 | ₹00 | --- |
| 21 Mar 2026 20.17 | ₹00 | --- |
| 15 Mar 2026 14.19 | ₹00 | --- |
| 14 Mar 2026 20.59 | ₹00 | --- |
| 13 Mar 2026 20.48 | ₹00 | --- |
| 12 Mar 2026 19.39 | ₹00 | --- |
| 11 Mar 2026 20.56 | ₹00 | --- |
FAQs
GSP Crop Science IPO Current GMP is ₹00.
GSP Crop Science IPO Expected Returns is 0.00%.
GSP Crop Science IPO estimated listing price is ₹00.